Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients
Clinical trial NCT02404389 · COMPLETED
Trial details
- NCT number
- NCT02404389
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-05
- Primary completion
- 2016-01-27
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.